-
Founded in:
1983-04-04 -
Country:
China -
Address:
No. 888, Yanchang Road, Chengguan District, Lanzhou City, Gansu Province -
Tax NO.:
916200002243483486 -
Registered Funds:
1,816.94 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain]) |
Inducing immune responses to protect against influenza virus infection
More
Inducing immune responses to protect against influenza virus infection |
ge;12mu;g | 0 | |
| Type A3 (Fujian/41I/02(H3N2) similar strain [NYMCX-147 strain]) |
Inducing immune responses to protect against influenza virus infection
More
Inducing immune responses to protect against influenza virus infection |
ge;12mu;g | 0 | |
| Type B (similar strains of B/Shanghai/36I/02 [B/Jiangsu/10/2003]) |
Inducing immune responses to protect against influenza virus infection
More
Inducing immune responses to protect against influenza virus infection |
ge;12mu;g | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Type A1 (New Caledonia/20/99 (H1N1) reassortant [IVR-116 strain]) |
Split vaccine, induces immune response, prevents influenza virus infection
More
Split vaccine, induces immune response, prevents influenza virus infection |
≥12mcg | 0 | |
| Type A3 (Fujian/41I/02(H3N2) similar strain [NYMCX-147 strain]) |
Split vaccine, induces immune response, prevents influenza virus infection
More
Split vaccine, induces immune response, prevents influenza virus infection |
≥12mcg | 0 | |
| Type B (similar strains of B/Shanghai/36I/02 [B/Jiangsu/10/2003]) |
Split vaccine, induces immune response, prevents influenza virus infection
More
Split vaccine, induces immune response, prevents influenza virus infection |
≥12mcg | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Group A meningococcal capsular polysaccharide |
Antibodies can be detected in the body 1 to 2 weeks after vaccination, reaching a peak at 12 weeks, and immunity can last at least 1 year, which can prevent epidemic cerebrospinal meningitis caused by group A meningococci.
More
Antibodies can be detected in the body 1 to 2 weeks after vaccination, reaching a peak at 12 weeks, and immunity can last at least 1 year, which can prevent epidemic cerebrospinal meningitis caused by group A meningococci. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Group A meningococcal polysaccharide antigen |
Antibodies can be detected in the body 1 to 2 weeks after vaccination, reaching a peak at 12 weeks, and immunity can last at least 1 year, which can prevent epidemic cerebrospinal meningitis caused by group A meningococci.
More
Antibodies can be detected in the body 1 to 2 weeks after vaccination, reaching a peak at 12 weeks, and immunity can last at least 1 year, which can prevent epidemic cerebrospinal meningitis caused by group A meningococci. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Influenza A (H1N1) virus split vaccine |
|
0 |